IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 42.906
EU - Europa 41.054
NA - Nord America 25.647
SA - Sud America 12.430
AF - Africa 1.088
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 25
AN - Antartide 1
Totale 123.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.442
RU - Federazione Russa 24.007
SG - Singapore 16.376
CN - Cina 11.858
BR - Brasile 10.249
HK - Hong Kong 6.169
SE - Svezia 4.503
IT - Italia 4.325
VN - Vietnam 4.200
FR - Francia 2.290
DE - Germania 1.295
IN - India 958
AR - Argentina 867
RO - Romania 827
GB - Regno Unito 789
FI - Finlandia 727
ID - Indonesia 538
CA - Canada 489
NL - Olanda 461
BD - Bangladesh 431
MX - Messico 427
EC - Ecuador 387
IQ - Iraq 370
IE - Irlanda 352
JP - Giappone 321
ZA - Sudafrica 305
TR - Turchia 300
ES - Italia 277
CO - Colombia 257
PL - Polonia 242
AT - Austria 228
UA - Ucraina 185
PY - Paraguay 171
PK - Pakistan 167
CL - Cile 145
VE - Venezuela 145
MA - Marocco 143
UZ - Uzbekistan 130
EG - Egitto 121
SA - Arabia Saudita 118
TN - Tunisia 99
AU - Australia 96
KE - Kenya 90
PE - Perù 85
PH - Filippine 85
NP - Nepal 80
MY - Malesia 77
IR - Iran 75
UY - Uruguay 73
AE - Emirati Arabi Uniti 69
LT - Lituania 69
JO - Giordania 66
DZ - Algeria 65
NG - Nigeria 63
DO - Repubblica Dominicana 61
AZ - Azerbaigian 60
CH - Svizzera 57
BE - Belgio 51
IL - Israele 51
KZ - Kazakistan 51
KR - Corea 39
TW - Taiwan 39
BO - Bolivia 37
CZ - Repubblica Ceca 35
GR - Grecia 34
TH - Thailandia 34
JM - Giamaica 33
BG - Bulgaria 32
LB - Libano 32
AL - Albania 31
HN - Honduras 30
OM - Oman 29
RS - Serbia 29
PT - Portogallo 28
SN - Senegal 27
TT - Trinidad e Tobago 27
BH - Bahrain 26
ET - Etiopia 25
CR - Costa Rica 24
NO - Norvegia 24
KW - Kuwait 23
PA - Panama 21
PS - Palestinian Territory 21
BA - Bosnia-Erzegovina 20
SV - El Salvador 20
DK - Danimarca 19
GT - Guatemala 19
BY - Bielorussia 18
TZ - Tanzania 18
HU - Ungheria 16
SY - Repubblica araba siriana 16
KG - Kirghizistan 15
NZ - Nuova Zelanda 15
XK - ???statistics.table.value.countryCode.XK??? 15
BB - Barbados 14
CI - Costa d'Avorio 14
LV - Lettonia 14
AO - Angola 13
GE - Georgia 13
MK - Macedonia 13
Totale 122.967
Salva come PNG Salva come JPEG
Città #
Singapore 6.678
Hong Kong 6.109
Moscow 5.742
Dallas 4.993
Ashburn 3.308
San Jose 3.230
Shanghai 2.286
Hefei 2.275
Lawrence 2.119
Princeton 2.113
Lauterbourg 1.940
Ho Chi Minh City 1.564
Beijing 1.060
Milan 940
Hanoi 899
New York 862
São Paulo 803
Helsinki 541
Los Angeles 537
Rio de Janeiro 349
Dublin 343
Orem 342
Rome 312
Santa Clara 311
Munich 296
Boardman 284
Nuremberg 238
Belo Horizonte 217
Chennai 199
Brasília 193
Da Nang 192
Warsaw 188
Tokyo 186
Guangzhou 172
Montreal 172
Brooklyn 171
Haiphong 170
Pune 170
Curitiba 158
Johannesburg 152
Frankfurt am Main 141
Porto Alegre 141
Denver 140
Turku 132
Atlanta 131
Baghdad 126
London 126
Quito 126
Campinas 124
Guayaquil 121
The Dalles 119
Chicago 118
Biên Hòa 113
Manchester 113
Mumbai 113
Seattle 113
Tashkent 113
Stockholm 111
Turin 111
Vienna 110
Mexico City 109
Phoenix 103
Tianjin 103
Amsterdam 102
Columbus 102
Guarulhos 101
Salvador 101
Poplar 99
Washington 99
Toronto 97
Thái Bình 96
Naples 95
Boston 93
Hangzhou 93
Houston 93
Hải Dương 93
Jakarta 93
Bologna 85
Ribeirão Preto 85
Dhaka 82
Council Bluffs 79
Paris 78
Florence 77
Goiânia 77
Manaus 76
Istanbul 74
Recife 74
Fortaleza 73
Shenzhen 70
Ankara 69
Buenos Aires 69
Caxias do Sul 67
Erbil 67
Nairobi 66
Ninh Bình 65
Santo André 64
Sumaré 62
Valencia 61
San Francisco 60
Montevideo 58
Totale 58.566
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.821
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.421
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 714
Benign Prostatic Hyperplasia and Its Aetiologies 456
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 394
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 383
High serum alpha-fetoprotein levels in primary infertile men 371
Women's sexual dysfunction: a pathophysiological review 303
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 210
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 210
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 207
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 205
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 185
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 180
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 179
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 178
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 176
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 171
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 171
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 166
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 162
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 161
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 154
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 153
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 146
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 146
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 146
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 144
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 142
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 139
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 138
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 137
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 136
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 134
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 134
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 133
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 131
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 131
A global approach to improving penile cancer care 130
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 130
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 129
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 129
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 128
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 127
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 127
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 126
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 126
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 126
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 125
[In Process Citation]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 125
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 125
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 125
How to Select the Optimal Candidates for Renal Mass Biopsy 125
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 124
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 124
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies 124
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 124
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 124
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 123
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 123
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life study 122
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 122
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 121
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 121
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 121
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 120
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 120
[Not Available]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 119
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 119
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 118
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 118
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 118
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 118
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 118
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 117
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 117
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 117
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 116
Clinical parameters associated with altered sperm DNA fragmentation index among primary infertile men: Findings from a real-life cross-sectional study 116
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 116
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 116
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 116
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 116
A risk calculator predicting recurrence in lymph node metastatic penile cancer 115
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 114
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 113
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 113
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 113
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 113
Does sildenafil enhance quality of nocturnal erections in healthy young men? A NPT-RigiScan (TM) study 113
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 113
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis 112
Pulmonary lesion after surgery for renal cancer: progression or new primary? 112
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 112
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 111
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 111
[Management and prevention of catheter-associated urinary tract infections: current opinions and clinical practice]. FT Gestione e prevenzionedelle infezioni delle vieurinarie associate a catetere:opinioni e pratica clinica. 111
Totale 18.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 836.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 836.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 6 8 2
2021/20221.273 1 58 30 577 61 65 90 75 42 69 55 150
2022/202310.126 4.873 1.738 601 119 68 1.013 434 606 272 96 151 155
2023/20245.160 235 279 399 356 413 922 292 508 90 383 562 721
2024/202529.158 4.249 726 542 672 691 2.350 4.169 2.213 5.247 4.330 1.813 2.156
2025/202678.026 5.690 7.391 7.341 12.527 5.552 1.933 7.576 5.681 21.004 3.331 0 0
Totale 124.500